(Adnkronos) - “Le sfide sono tantissime: la prima è l’alleanza tra tutti gli esperti e gli scienziati che si occupano di cervello, dalla psichiatria alla neurologia nella neuropsichiatria infantile, così come nelle fasi avanzate dell'età e quindi della geriatria e di combinare insieme agli psicologi, ai farmacologi e ai biologi, una vera e propria comunità dedicata alla salute del cervello. La seconda sfida è di far comprendere alla comunità e alla cittadinanza che ‘One Health’ non è uno slogan fine a se stesso, ma” per ricordare che “non c'è un cervello in salute se c'è un corpo malato e viceversa”. Con queste parole Alessandro Padovani, presidente Società Italiana di Neurologia - Sin, è intervenuto/a all’evento istituzionale ‘La salute parte dal cervello. Le Neuroscienze in Italia. Passato, presente e futuro’ promosso a Roma da Lundbeck Italia, azienda biofarmaceutica danese specializzata nelle neuroscienze, in occasione del 30° anniversario di attività e impegno nel nostro Paese.
Category
🗞
NewsTranscript
00:00The challenges are many. The first challenge is to ally with all the experts, the scientists
00:14who deal with the brain, from psychiatry to neurology, in child neuropsychiatry, as well
00:20as in the advanced stages of age and therefore geriatrics. And to combine together with
00:26psychologists, pharmacologists, biologists, a real community dedicated to the health
00:33of the brain. The second challenge is to make the community and the citizens understand
00:39that One Health is not a slogan in itself, but that there is no healthy brain if there
00:46is a sick body and vice versa. You can't have a healthy body if the brain doesn't
00:53function properly. But this is already an element. The other element is that we must
00:59strive to understand how the environment that depends on us pays if we do not respect
01:07the environment. And there are several evidences that diseases of the body, as well as of the
01:14brain, are strongly conditioned. Let's just think of Covid recently. So the challenges
01:20are to understand how everything is united, but how at the same time we must come to
01:26identify for each condition, each disease, what are the real mechanisms and act on
01:33these. We can certainly act through prevention, which we are strongly committed to, but
01:40also in the development of drugs or treatments. Not all treatments are pharmacological,
01:46it must be said. I must say that Elon Musk, to quote one, has opened a new frontier,
01:53that of Neuralink, but that of stimulators and the interface between the brain and artificial
02:00intelligence. I believe that this is still a boundary to explore and I believe that in
02:06the coming years there will be very strong news in this area.